
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
Interesting. Ive got a heavy drug seeking population. Possibly eliminate opioids in future.
Whats better is its was studied with bunionectomies. Should make getting it approved easier for us.